Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Blossomhill Therapeutics, Inc. (BLSM) since 2026 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Blossomhill Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1839970.
Total stock buying since 2026: $25,181,900.
Total stock sales since 2026: $0.
Total stock option exercises since 2026: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 1,573,900 | $25,181,900 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-08 | 1,573,900 | $25,181,900 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-08-10 | Liptak Vincent Paul (General Counsel) | Buy | 2,200 | 16.00 | 35,200 |
| 2026-08-10 | Cormorant Private Healthcare Fund Vi, Lp | Buy | 312,500 | 16.00 | 5,000,000 |
| 2026-08-10 | Orbimed Capital Gp Viii Llc | Buy | 625,000 | 16.00 | 10,000,000 |
| 2026-08-10 | Keyes Jason A (Chief Financial Officer) | Buy | 700 | 16.00 | 11,200 |
| 2026-08-10 | Schmid John P. | Buy | 6,000 | 16.00 | 96,000 |
| 2026-08-10 | Gordon Carl L | Buy | 625,000 | 16.00 | 10,000,000 |
| 2026-08-07 | Liptak Vincent Paul (General Counsel) | Buy | 2,500 | 15.80 | 39,500 |
Insider trading activities including stock purchases, stock sales, and option exercises of BLSM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Blossomhill Therapeutics, Inc. (symbol BLSM, CIK number 1839970) see the Securities and Exchange Commission (SEC) website.